Author(s):
Rodrigues, Célia Fortuna ; Rodrigues, E. ; Silva, Sónia Carina ; Azeredo, Joana ; Henriques, Mariana
Date: 2015
Persistent ID: http://hdl.handle.net/1822/37878
Origin: RepositóriUM - Universidade do Minho
Project/scholarship:
info:eu-repo/grantAgreement/FCT/5876-PPCDTI/119069/PT
;
info:eu-repo/grantAgreement/FCT/COMPETE/119069/PT;
info:eu-repo/grantAgreement/FCT/5876-PPCDTI/126270/PT
;
info:eu-repo/grantAgreement/FCT/COMPETE/126270/PT;
info:eu-repo/grantAgreement/FCT/3599-PPCDT/132966/PT;
Subject(s): Candida glabrata; Biofilms; Resistance Mechanisms; Antifungals; Matrix; Science & Technology; Ciências Médicas::Biotecnologia Médica
Description
Candida species are responsible for recurrent human infections, mostly in immunocompromised patients, due to their high vulnerability. Candida glabrata has been shown to have a major role in these infections being the second most prevalent species involved in human fungemia. Objective: To understand the effect of three different antifungal agents Fluconazole (Flu), Amphotericin B (AmB) and Caspofungin (Csf) - in C. glabratas biofilm formation, specially their role on matrix composition.
Programa Operacional, Fatores de competitividade – COMPETE and by national funds through FCT – Fundação para a Ciência e a Tecnologia on the scope of the projects FCT PTDC/SAU-MIC/119069/2010, RECI/EBB- EBI/0179/2012, PEst-OE/EQB/LA0023/2013 Project “BioHealth - Biotechnology and Bioengineering approachesto improvehealthquality",Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON.2 – O Novo Norte), QREN, FEDER
